|
Pharma Marketletter
Click on article title to view & purchase. Articles are sorted by their publication date in reverse chronological order.
Total result: 265 articles |
 Page 1 of 4 
|
USP announces new standards.
February 23, 2009
Ligand swings to loss on merger and legal fees.
February 23, 2009
Deeper loss for Vertex on high costs, low sales.
February 23, 2009
China health reform.
February 23, 2009
JPMA sets up tax-related task force.
February 23, 2009
Indian President backs affordable drugs.
February 23, 2009
PhRMA calls for Japan to relax appro rules.
February 23, 2009
GlaxoSmithKline's CEO Andrew Witty outlines new global public health a...
February 23, 2009
GPC Biotech and Agennix to merge.
February 23, 2009
Sanofi eyeing Brazil generics firm?
February 23, 2009
Merck KGaA sees 2008 loss on acquisition costs and crystals, but pharm...
February 23, 2009
Japan stock market week to Feb 16, 2009.
February 23, 2009
Sequella gets NHI grant for TB drug development.
February 23, 2009
FDA panel says Darvon risks outweigh benefits.
February 23, 2009
Cadence Pharma to raise $86.6M.
February 23, 2009
Mutual insurer claims DTC harm for generics.
February 23, 2009
Novartis pulls Sandoz out of IFPMA.
February 23, 2009
Takeda/Teijin gain US OK for new gout drug.
February 23, 2009
Sanofi starts Ph II C. Difficile vaccine study.(Clinical report)
February 23, 2009
Richter to market HRA Pharma prods.
February 23, 2009
MSD withdraws MA for vorinostat in EU.
February 23, 2009
Pharming's 2008 loss worsens by 21%.
February 23, 2009
Teva profit down 67% on Barr merger costs.(Financial report)
February 23, 2009
Amgen/Takeda resume motesanib development.
February 23, 2009
Ark's Cerepro for brain tumors gets first Named Patient Supply approva...
February 23, 2009
La Jolla Pharma in jeopardy after pivotal Riquent trial is abandoned a...
February 23, 2009
44 fake drug incidents in Switzerland in 2008.
February 23, 2009
European Parliament's Health Committee meets with Commissioner Verheug...
February 23, 2009
Novartis may launch meningitis vacc by 2011.
February 23, 2009
Cancer researchers find "danger" receptor.
February 23, 2009
GSK and Theravance report strong ICS results.(Clinical report)
February 23, 2009
Amarillo hep C agent cleared for Ph II in Taiwan.
February 23, 2009
Roche reinstated to ABPI membership.
February 23, 2009
10 years of drugmaker action against lymphatic filiarisis.
February 23, 2009
Drugmakers remain attractive employers in Belgium.
February 23, 2009
Biotech set to outperform health care.
February 23, 2009
New findings raise questions on process to identify R&D drugs for rare...
February 23, 2009
Coartem Disp debuts in Africa.
February 23, 2009
blue nspection to offer exipient and API audits in Asia.
February 23, 2009
B-MS Foundation funding for hep C prevention and education.
February 23, 2009
North Dakota blocks cheap Rx drugs.
February 23, 2009
US patients "beware of Rx switching".
February 23, 2009
Curagen undertakes strategic review as share price does not reflect "i...
February 23, 2009
Action Pharma names Torben Laursen as VP of business development.
February 23, 2009
Parexel Consulting recruits Anders Neil.
February 23, 2009
Pharmaxis names Howard Fox as CMO.
February 23, 2009
Novo Nordisk promotes Andy Ajello to VP, national diabetes sales.
February 23, 2009
New JV Teva Kowa Pharma names Nobuyoshi Inoue as president.
February 23, 2009
Otsuka appoints Mark Altmeyer as permanent CEO.
February 23, 2009
Abbott and Enanta to begin Ph I HCV trial.
February 23, 2009
OctoPlus launches equity offering.
February 23, 2009
CVS pays govt $2.25M and toughens practices.
February 23, 2009
FDA reiterates position on Gilead response.(Clinical report)
February 23, 2009
Stock Commentary - New York week to Feb 16, 2009.
February 23, 2009
Forthcoming meetings and conferences.(Conference news)
February 23, 2009
UK's RPSGB report calls for better Rx safety.
February 23, 2009
Spain's Farmaindustria: pharma is growth option.
February 23, 2009
RPSGB attacks physician "bribes" to cut Rxing.
February 23, 2009
Panel views "healthy donuts" via nano-tech.
February 23, 2009
Soy may reduce colorectal cancer risk.
February 23, 2009
Glioma vacc gives 25% survival at five years.
February 23, 2009
Wakamoto develops diabetic retinopathy injection.
February 23, 2009
Vical presents on flu vacc to WHO.(Clinical report)
February 23, 2009
Pharmos to sell certain CB2 selective agonists.
February 23, 2009
FDA accepts Amgen's denosumab BLA.
February 23, 2009
FDA sets PDUFA date for Zogenix' Sumavel.
February 23, 2009
Drug identified to treat opioid addiction.
February 23, 2009
Biotage enters peptide synthesis business.
February 23, 2009
Algeta raises $35M for alpharadin devel't.
February 23, 2009
Opsona Thera closes 18M-euro funding.
February 23, 2009
PDCO refuses PIPs for Lilly, Allergan, Neurim and AZ.
February 23, 2009
GSK doses first patient in Ph III Syncria trial.
February 23, 2009
Roche's Valcyte works up to 200 days; trial.
February 23, 2009
Organon drug linked with breast cancer.
February 23, 2009
Llamas way forward for antibody drugs.
February 23, 2009
|
1